João Martins e Silva *

Autor invitado por SIIC

Potencial importancia da dieta na estrutura e funcionalidade vascular e complicações patológicas relacionadas

INTERACÇÕES POSITIVAS OU NEGATIVAS DA DIETA COM A PAREDE VASCULAR

As características estruturais e funcionais do endotélio vascular tendem a ser profundamente afectadas pela composição da dieta consumida habitualmente. Dietas ricas em gorduras saturadas são causa frequente de hipercolesterolemia e de outros tipos de dislipidemia, que se repercutem na disfunção endotelial, desenvolvimento da aterosclerose e subsequentes complicações tromboembólicas.

*João Martins e Silva
describe para SIIC los aspectos relevantes de su trabajo
DIETA, ATEROSCLEROSE E COMPLICAÇÕES ATEROTROMBÓTICAS
Institución principal de la investigación
*Universidade de Lisboa, Lisboa, Portugal
Imprimir nota

Comprar este artículo
Otros artículos escogidos

Referencias bibliográficas
1. Keys A. Coronary heart disease in seven countries. Circulation 41(Suppl. I):1-211, 1970.

2. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health 41:279-281, 1951.

3. Ross R. The pathogenesis of atherosclerosis--an update. N Engl J Med 314:488-500, 1986.

4. Lee RT, Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol 17:1859-1867, 1997.

5. Blair A, Shaul PW, Yuhanna IS, Conrad PA, Smart EJ. Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation. J Biol Chem 274:32512-32519, 1999.

6. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915-924, 1989.

7. Galle J, Hansen-Hagge T, Wanner C, Seibold S. Impact of oxidized low density lipoprotein on vascular cells. Atherosclerosis 185:219-226, 2006.

9. Selwyn AP, Kinlay S, Libby P, Ganz P. Atherogenic lipids, vascular dysfunction, and clinical signs of ischemic heart disease. Circulation 95:5-7, 1997.

10. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 325:373-381, 1991.

11. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng Z.J, Legal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC Jr, Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113:e85-e151, 2006.

12. Stamler J. The marked decline in coronary heart disease mortality rates in the United States, 1968-1981: summary of findings and possible explanations. Cardiology 72:11-22, 1985.

13. Hingorani AD. Diet, the endothelium and atherosclerosis. Clin Sci 106:447-448, 2004.

14. Mehta NJ, Khan IA. Cardiology's 10 greatest discoveries of the 20th century. Tex Heart Inst J 29:164-171, 2002.

15. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 326:242-250, 1992.

16. Stehbens WE. The experimental and iatrogenic production of atherosclerosis. In: Recent progress in cardiovascular mechanics: From basic research to clinical application, Hosada S, Yagunima T, Sugarwara M, Taylor MG, Caro CG (eds), London: Gordon & Bread 253-268, 1994.

17 Jones GT, Stehbens WE. The ultrastructure of arteries proximal to chronic experimental carotid-jugular fistulae in rabbits. Pathology 27:36-42, 1995.

18. Gimbrone MA Jr. Endothelial dysfunction, hemodynamic forces, and atherosclerosis. Thromb Haemost 82:722-726, 1999.

19. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) - Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106:3143-3421, 2002.

20. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ. Coordinating Committee of the National Cholesterol Education Program - Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Arterioscler Thromb Vasc Biol 24:e149-e161, 2004.

21. Kinsell LW, Partridge J, Boling L, Margen S, Michaels G. Dietary modification of serum cholesterol and phospholipid levels. J Clin Endocrinol Metab 12:909-913, 1952.

22. McCarron DA, Oparil S, Chait A, Haynes RB, Kris-Etherton P, Stern JS, Resnick LM, Clark S, Morris CD, Hatton DC, Metz JA, McMahon M, Holcomb S, Snyder GW, Pi-Sunyer FX. Nutritional management of cardiovascular risk factors. A randomized clinical trial. Arch Intern Med 157:169-177, 1997.

23. Kris-Etherton PM, Yu S. Individual fatty acid effects on plasma lipids and lipoproteins: human studies. Am J Clin Nutr 65:1628S-1644S, 1997.

24. Kappagoda CT, Hyson DA, Amsterdam EA. Lowcarbohydrate- high-protein diets: is there a place for them in clinical cardiology? J Am Coll Cardiol 43:725-730, 2004.

25. Westman EC, Yancy WS Jr, Olsen MK, Dudley T, Guyton JR. Effect of a low-carbohydrate, ketogenic diet program compared to a low-fat diet on fasting lipoprotein subclasses. Int J Cardiol 110:212-216, 2006.

26. Katan MB, Grundy SM, Willett WC. Should a low-fat, highcarbohydrate diet be recommended for everyone? Beyond low-fat diets. N Engl J Med 337:563-566, 1997.

27. Weinberg SL. The diet-heart hypothesis: a critique. J Am Coll Cardiol 43:731-733, 2004.

28. Hooper L, Summerbell CD, Higgins JP, Thompson RL, Capps NE, Smith GD, Riemersma RA, Ebrahim S. Dietary fat intake and prevention of cardiovascular disease: systematic review. BMJ 322:757-763, 2001.

29. Keys A, Anderson JT, Grande F. Prediction of serum-cholesterol responses of man to changes in fats in the diet. Lancet 273:959-66, 1957.

30. Bang HO, Dyerberg J, Sinclair HM. The composition of the Eskimo food in north western Greenland. Am J Clin Nutr 33:2657-2661, 1980.

31. Erkkila AT, Lichtenstein AH, Mozaffarian D, Herrington DM. Fish intake is associated with a reduced progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease. Am J Clin Nutr 80:626-632, 2004.

32. He K, Song Y, Daviglus ML, Liu K, Van Horn L, Dyer AR, Greenland P. Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 109:2705-2711, 2004.

33. Watts GF, Lewis B, Brunt JN, Lewis ES, Coltart DJ, Smith LD, Mann JI, Swan AV. Effects on coronary artery disease of lipidlowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet 339:563-569, 1992.

34. Harper CR, Jacobson TA. Usefulness of omega-3 fatty acids and the prevention of coronary heart disease. Am J Cardiol 96:1521-1529, 2005.

35. Key TJ, Fraser GE, Throgood M, Appleby PN, Beral V, Reeves G, Burr ML, Chang-Claude J, Frentzel-Beyme R, Kuzma JW, Mann J, McPherson K. Mortality in vegetarians and non-vegetarians: a collaborative analysis of 8300 deaths among 76,000 men and women in five prospective studies. Public Health Nutr 1:33-41, 1998.

36. Key TJ, Appleby PN, Rosell MS. Health effects of vegetarian and vegan diets. Proc Nutr Soc 65:35-41, 2006.

37. Pereira MA, O'Reilly E, Augustsson K, Fraser GE, Goldbourt U, Heitmann BL, Hallmans G, Knekt P, Liu S, Pietinen P, Spiegelman D, Stevens J, Virtamo J, Willett WC, Ascherio A. Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med 164:370-376, 2004.

38. Gylling H, Miettinen TA. The effect of plant stanol- and sterolenriched foods on lipid metabolism, serum lipids and coronary heart disease. Ann Clin Biochem 42:254-263, 2005.

39. Kinsell LW, Partridge J, Boling L, Margen S, Michaels G. Dietary modification of serum cholesterol and phospholipid levels. J Clin Endocrinol Metab 12:909-913, 1952.

40. Trichopoulou A, Bamia C, Trichopoulos D. Mediterranean diet and survival among patients with coronary heart disease in Greece. Arch Intern Med 165:929-935, 2005.

41. De Lorgeril M, Salen P, Martin JL, Monjand I, Delaye J, Mamelle U. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction. Final report of the Lyon Diet Heart Study. Circulation 99:779-785, 1999.

42. Perona JS, Cabello Moruno R, Ruiz Gutiérrez V. The role of virgin olive oil components in the modulation of endothelial function J Nutr Biochem 17:429-445, 2006.

43. De Lorgeril M, Salen P, Martin JL, Mamelle N, Monjaud I, Touboul P, Delaye J. Effect of a Mediterranean type of diet on the rate of cardiovascular complications in patients with coronary artery disease. Insights into the cardioprotective effect of certain nutriments. J Am Coll Cardiol 28:1103-1108, 1996.